Serina Therapeutics GAAP EPS of -$0.66 misses by $0.24, revenue of $0.13M

2 hours ago 1

Serina Therapeutics press release (NYSE:SER): Q2 GAAP EPS of -$0.66 misses by $0.24.
Revenue of $0.13M (+160.0% Y/Y).
Cash and cash equivalents totaled $6.0 million as of June 30, 2025.
The Company projects its cash and cash equivalents as of June 30, 2025 to fund operations into the fourth quarter of 2025.

Recommended For You